Yahoo Finance
Search documents
Best CD rates today, February 20, 2026 (up to 4% APY return)
Yahoo Finance· 2026-02-20 11:00
See which banks are currently paying the highest CD rates. If you’re looking for a secure place to store your savings, a certificate of deposit (CD) may be a great choice. These accounts often provide higher interest rates than traditional checking and savings accounts. However, CD rates can vary widely. Learn more about CD rates today and where to find high-yield CDs with the best rates available. Banks with the best CD rates right now Today’s CD rates vary quite a bit. In general, however, CD rates hav ...
Best high-yield savings interest rates today, February 20, 2026 (up to 4% APY return)
Yahoo Finance· 2026-02-20 11:00
Find out if now is the right time to put your money in a savings account. In 2024, the Federal Reserve implemented a series of cuts to the federal funds rate and those rates continued on a downward trend throughout 2025. As a result, deposit interest rates have fallen from their historic highs. Still, it's possible to find high-yield savings accounts paying above 4% APY. So, if you’re looking for the best rates available today, here’s a breakdown of where to find them. What bank currently has the highest ...
Piper Sandler Lowers Akebia Therapeutics (AKBA) PT to $4 as Firm Updates Estimates Following Year-End Reports
Yahoo Finance· 2026-02-20 00:28
Disclosure: None. This article is originally published at Insider Monkey. Photo by RephiLe water on Unsplash Akebia Therapeutics Inc. (NASDAQ:AKBA) is a biopharmaceutical company that develops and commercializes therapeutics for patients with kidney diseases. While we acknowledge the potential of AKBA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly fro ...
DA Davidson Downgrades LiveRamp (RAMP) PT Despite Strong FQ3 Earning, Buy Rating
Yahoo Finance· 2026-02-20 00:28
LiveRamp Holdings Inc. (NYSE:RAMP) is one of the best growth stocks to buy for the next 20 years. On February 6, DA Davidson lowered its price target on LiveRamp to $35 from $45 with a Buy rating. Although the company exceeded top and bottom-line expectations in FQ3 2026, management left its fiscal year 2026 guidance unchanged. The analyst attributed this cautious outlook to the timing of specific project-based expenses shifting into FQ4 and marketplace growth that came in softer than previously anticipated ...
TD Cowen Downgrades Cellebrite (CLBT) Citing Market Contraction Despite Strong Recurring Revenue Growth
Yahoo Finance· 2026-02-20 00:28
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Copyright: squidmediaro / 123RF Stock Photo Cellebrite DI Ltd. (NASDAQ:CLBT) develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. While we acknowledge the potential of CLBT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that a ...
Compass Point Upgrades Upstart (UPST) to Neutral, Ups PT to $30 Citing Ambitious 2028 Outlook
Yahoo Finance· 2026-02-20 00:28
Upstart Holdings Inc. (NASDAQ:UPST) is one of the best growth stocks to buy for the next 20 years. On February 17, following the company’s Q4 2025 earnings report, Compass Point analyst Giuliano Bologna upgraded Upstart from Sell to Neutral and raised the price target to $30 from $20. Bologna noted that while the company’s 2028 outlook is ambitious, successful execution would make the shares less expensive and provide a potential case for upside. On February 13, Goldman Sachs upgraded Upstart to Neutral ...
Needham Keeps Buy Rating on Klaviyo (KVYO), Highlights Strong Core Metrics, Successful Segment Execution
Yahoo Finance· 2026-02-20 00:28
Klaviyo Inc. (NYSE:KVYO) is one of the best growth stocks to buy for the next 20 years. On February 11, Needham analyst Scott Berg lowered the firm’s price target on Klaviyo to $30 from $45 but maintained a Buy rating following a very strong Q4 2025 earnings report. The company achieved high-end revenue outperformance fueled by robust sales and customer expansion during the holiday season. The analyst highlighted that despite the price target reduction, Klaviyo’s core metrics remain strong, reflecting succ ...
Needham Lowers DraftKings (DKNG) PT to $35 Following Earnings Miss, Reduced Revenue Outlook
Yahoo Finance· 2026-02-20 00:28
DraftKings Inc. (NASDAQ:DKNG) is one of the best growth stocks to buy for the next 20 years. On February 17, Needham lowered its price target on DraftKings to $35 from $52 with a Buy rating following a Q4 2025 earnings miss and a reduced revenue outlook for fiscal year 2026. While the firm expects the upcoming investor day to be beneficial, the analyst argued that the company must develop a prediction market product on par with Kalshi to drive meaningful revenue and cash flow. Northland analyst Greg Giba ...
BofA Reinstates Fair Isaac (FICO) Coverage With Buy Rating, $1,900 PT Citing Strong Pricing Power
Yahoo Finance· 2026-02-20 00:28
Fair Isaac Corporation (NYSE:FICO) is one of the best growth stocks to buy for the next 20 years. On February 17, Bank of America analyst Curtis Nagle reinstated coverage of FICO with a Buy rating and a $1,900 price target, highlighting the company’s strong pricing power and the growth potential of its Mortgage Direct Licensing program. This move was part of a broader reinstatement of 19 stocks within the Information and Business Services sector, for which the firm holds a generally constructive outlook. ...
Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
Yahoo Finance· 2026-02-20 00:28
Lam Research Corporation (NASDAQ:LRCX) is one of the best growth stocks to buy for the next 20 years. Earlier on January 29, TD Cowen raised its price target on Lam Research to $290 from $170 while keeping a Buy rating. The firm identified the 2026 Wafer Fabrication Equipment/WFE outlook of $135 billion as a major positive surprise, particularly when considering the current constraints in cleanroom availability. On the same day, RBC Capital raised its price target on Lam Research to $290 from $260 and ma ...